Legal Opinion
Genentech, Inc. v. Boehringer Mannheim GmbH
District Court, D. Massachusetts
Decided April 14, 1999No. Civ.A. 96-11090-PBSPublishedCited by 1 opinion
1Opinion of the Court
MEMORANDUM AND ORDER
SARIS, District Judge.
INTRODUCTION
Defendants Boehringer Mannheim GmbH and Boehringer Mannheim Corporation (“collectively BM”) have moved for summary judgment on the claims of plaintiff Genentech, Inc. (“Genentech”) that BM infringes three patents involving Genen-tech’s tissue plasminogen activator (“t-PA”) product. The three patents are United States Patent Nos. 4,342,832 (“the ’832 patent”); 5,034,225 (“the ’225 patent”); and 4,511,502 (“the ’502 patent”). Genentech has filed a cross-motion for summary judgment with respect to the ’502 patent. After hearings held on June…
2Cases cited17 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Warner-Jenkinson Co. v. Hilton Davis Chemical Co.Supreme Court of the United States · 1997
- Robert Conroy v. Reebok International, Ltd.Court of Appeals for the Federal Circuit · 1994
12 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Monsanto Co. v. Mycogen Plant Science, Inc.District Court, D. Delaware · 1999